Scientists have used advanced X-ray phase-contrast tomography (XPCT) to uncover how gut health may influence Alzheimer’s disease.

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Research indicates longer REM latency is associated with higher Alzheimer's biomarkers, pointing to its potential as an early ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

The study indicated delayed REM sleep is a novel marker or risk factor for AD/ADRD pathogenesis. Throughout the study, Prolonged REML (rapid eye movement latency) was associated with higher amyloid ...

Prolonged rapid eye movement (REM) latency may be a potential marker for Alzheimer disease and Alzheimer disease and related ...

Summary: Delayed rapid eye movement (REM) sleep may be an early indicator of Alzheimer’s disease. Researchers found that participants with delayed REM sleep had higher levels of toxic proteins ...

Gaps remain in biomedical research in frontotemporal dementia; however, there are several means by which these gaps can be bridged.

The authors of the study suggest that picking one’s nose “may” introduce the kind of bacteria that will, in the long term, ...

Research comparing different approaches to dementia care for people with Alzheimer's disease and other dementias found no significant differences in patient behavioral symptoms or caregiver strain, ...

To better understand the challenges and opportunities in research and development of medicines for Alzheimer's disease from a regulatory perspective, the EU Innovation Network has released a Horizon ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.